Clinical Trial Update: Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders [Phase 3]

View source ↗

Summary

This Phase 3 trial update summarizes the study evaluating bezafibrate to achieve complete biochemical response in non-responders with primary biliary cholangiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Bezafibrate (bezafibrate)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: UNKNOWN